An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to message these accounts directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.
Several professionals stated the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and customer regulations, risking fines, legal action or prison.
Platform Reaction and Content Elimination
Based on TikTok, the service has removed problematic content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Trading Operations
Research also found groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, populated with photos of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at residence.
After moments of entering one community, a seller shared contact information, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, health issues or past usage.
Item Information and Pricing
Inside these groups, messages display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service stated it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.
Her staff has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to potentially serious health risks”.
